The costs of treating curable sexually transmitted infections in low- and middle-income countries: A systematic review

Sexually Transmitted Diseases

Volumn 33, Issue 10 SUPPL., 2006, Pages

  Terris Prestholt, Fern ^a   Vyas, Seema ^a   Kumaranayake, Lilani ^a   Mayaud, Philippe ^a   Watts, Charlotte ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECONOMICS; HEALTH CARE COST; HUMAN; MEDLINE; REGRESSION ANALYSIS; SEXUALLY TRANSMITTED DISEASE;

AFRICA SOUTH OF THE SAHARA; ANTI-INFECTIVE AGENTS; ASIA; COSTS AND COST ANALYSIS; DEVELOPING COUNTRIES; EUROPE; FEMALE; HUMANS; MALE; PERU; REGRESSION ANALYSIS; SEXUALLY TRANSMITTED DISEASES;

EID: 33749039452     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000235177.30718.84     Document Type: Article

References (71)

1. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overviews and Estimates. Geneva: World Health Organization, 2001.
2. World Development Report 1993: Investing in Health. New York: Oxford University Press for the World Bank, 1993.
3. Mayaud P, Ndowa F, Richens J, Mabey D. Sexually transmitted infections. In: Parry E, Mabey D, Gill G, Godfrey R, eds. Principles of Medicine in Africa. Cambridge: Cambridge University Press, 2004.
4. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
5. Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: Old problems and modern challenges. Sex Transm Infect 2004; 80:174-182.
6. Prevention and Control of Sexually Transmitted Infections: Draft Global Strategy. Geneva: World Health Organization, 2006.
7. Sexually Transmitted Diseases: Policies and Principles for Prevention and Care. UNAIDS Best Practice Collection. Geneva: WHO/UNAIDS, 1997.
8. Creese A, Parker D. Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva: World Health Organization, 1994.
9. Schwartlander B, Stover J, Walker N, et al. AIDS. Resource needs for HIV/AIDS. Science 2001; 292:2434-2436.
10. Kumaranayake L, Pepperall J, Goodman H, et al. Costing Guidelines for HIV Prevention Strategies. UNAIDS, 2000.
11. International AIDS Society. 15th International AIDS Conference, Bangkok, 2004.
12. The 16th Biennial Meeting of the International Society for Sexually Transmitted Diseases Research (ISSTDR). Amsterdam, 2006.
13. World Bank. Country groups by income. World Bank. Available at: http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0, contentMDK: 20421402~menuPK:64133156~pagePK:64133150~piPK: 64133175~theSitePK:239419,00. html. 2006.
14. Kumaranayake L. How to do (or not to do). The real and the nominal? Making inflationary adjustments to cost and other economic data. Health Policy and Planning 2000; 15:230-234.
15. ERS International Macroeconomic Data Set. Economic Research Service, US Department of Agriculture, 2005.
16. Adams EJ, Garcia PJ, Garnett GP, et al. The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis 2003; 30:379-387.
17. Borghi J, Gorter A, Sandiford P, Segura Z. The cost-effectiveness of a competitive voucher scheme to reduce sexually transmitted infections in high-risk groups in Nicaragua. Health Policy and Planning 2005; 20:222-231.
18. Carrara V, Terris-Prestholt F, Kumaranayake L, Mayaud P. Operational and economic evaluation of an NGO-led sexually transmitted infections intervention: North-western Cambodia. Bull World Health Organ 2005; 83:434-442.
19. Chout RT, Vaton S, Duval-Violton D, et al. Screening for Chlamydia trachomatis infection in pregnant women in Martinique. Sex Transm Dis 1995; 22:221-227.
20. Cornier N, Petrova E, Cavailler P, et al. Performance and costs of various approaches for the management of vaginal discharge and cervical infections in Sofia, Bulgaria. 2004.
21. Dandona L, Sisodia P, Prasad TL, et al. Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Serv Res 2005; 5:69.
22. Djajakusumah T, Sudigdoadi S, Keersmaekers K, Meheus A. Evaluation of syndromic patient management algorithm for urethral discharge. Sex Transm Infect 1998; 74(suppl 1):S29-33.
23. Forsythe S, Mangkalopakorn C, Chitwarakorn A, Masvichian N. Cost of providing sexually transmitted disease services in Bangkok. AIDS 1998; 12(suppl 2):S73-80.
24. Guinness L, Kumaranayake L, Rajaraman B, et al. Does scale matter? The costs of HIV-prevention interventions for commercial sex workers in India. Bull World Health Organ 2005; 83:747-755.
25. Hawkes S, Morison L, Foster S, et al. Reproductive-tract infections in women in low-income, low-prevalence situations: Assessment of syndromic management in Matlab, Bangladesh. Lancet 1999; 354:1776-1781.
26. Kourbatova E, Akovbyan V, Chesson H, et al. Assessment of the routine screening program for STI in occupational groups in Moscow, Russia: Cost-effectiveness analysis. International Society of Sexually Transmitted Disease Research (ISSTDR), Amsterdam, Netherlands, 2004.
27. Liu H, Jamison D, Li X, et al. Is syndromic management better than the current approach for treatment of STDs in China? Evaluation of the cost-effectiveness of syndromic management for male STD patients. Sex Transm Dis 2003; 30:327-330.
28. Phaosavasdi S, Snidvongs W, Thasanapradit P, et al. Cost-benefit analysis of diagnosis and treatment of syphilis in pregnant women. J Med Assoc Thai 1987; 70:90-95.
29. Rathore AS, Misra RS, Ramesh V. Domiciliary health counselling in patients with sexually transmitted diseases. J Commun Dis 1997; 29:35-39.
30. Vishwanath S, Talwar V, Prasad R, et al. Syndromic management of vaginal discharge among women in a reproductive health clinic in India. Sex Transm Infect 2000; 76:303-306.
31. Wang Q, Yang P, Zhong M, Wang G. Validation of diagnostic algorithms for syndromic management of sexually transmitted diseases. Chin Med J (Engl) 2003; 116:181-186.
32. Soderlund N, Lavis J, Broomberg J, Mills A. The costs of HIV prevention strategies in developing countries. Bull World Health Organ 1993; 71:595-604.
33. Kumaranayake L, Watts C. Cost-effectiveness estimates of the Mwanza sexually transmitted diseases intervention. Lancet 1998; 351:989-990.
34. Walker D. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: Is there an evidence base? Health Policy and Planning 2003; 18:4-17.
35. Terris-Prestholt F, Watson-Jones D, Mugeye K, et al. Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect 2003; 79:375-381.
36. Vickerman P, Terris-Pretholt F, Delany-Moretlwe S, et al. Are targeted HIV-prevention activities cost-effective in high prevalence settings? Results from STI treatment intervention for sexworkers in Johannesburg, South Africa. Sex Transm Dis. 2006; May 25; PMID: 16735954.
37. Gomo E, Ndamba J, Murahwa S, et al. In vitro activity of several antimicrobial agents against Neisseria gonorrhoeae and comparison of cost of treatment. Cent Afr J Med 1995; 41:83-86.
38. Van der Veen F, Fransen L. Drugs for STD management in developing countries: choice, procurement, cost, and financing. Sex Transm Infect 1998; 74(suppl 1):S166-174.
39. Costello Daly C, Franco L, Chilongozi DA, Dallabetta G. A cost comparison of approaches to sexually transmitted disease treatment in Malawi. Health Policy and Planning 1998; 13:87-93.
40. Parker KA, Koumans EH, Hawkins RV, et al. Providing low-cost sexually transmitted diseases services in two semi-urban health centers in Central African Republic (CAR): Characteristics of patients and patterns of health care-seeking behavior. Sex Transm Dis 1999; 26:508-516.
41. Watts C, Goodman H. Resource Allocation for HIV Prevention. Report on Pilot Study in Zambia. WHO/GPA and The London School of Hygiene and Tropical Medicine, 1993.
42. Over M, Piot P. HIV infection and sexually transmitted diseases. In: Mamison D, Mosley WH, Measham A, Mobadilla J, eds. Disease Control Priorities in Developing Countries. New York: Oxford University Press, 1993:455-527.
43. Gilson L, Mkanje R, Grosskurth H, et al. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania. Lancet 1997; 350:1805-1809.
44. Crabbe F, Vuylsteke B, de Clerck M, Laga M. Cost-effectiveness of management strategies for acute urethritis in the developing world. Trop Med Int Health 2000; 5:640-647.
45. Harrison A, Karim SA, Floyd K, et al. Syndrome packets and health worker training improve sexually transmitted disease case management in rural South Africa: Randomized controlled trial. AIDS 2000; 14:2769-2779.
46. Walker D, Muyinda H, Foster S, et al. The quality of care by private practitioners for sexually transmitted diseases in Uganda. Health Policy and Planning 2001; 16:35-40.
47. West B, Morison L, Schim van der Loeff M, et al. Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in The Gambia. Sex Transm Dis 2003; 30:483-489.
48. Price MA, Stewart SR, Dow WH, et al. The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking STI care in Malawi. 15th International AIDS Conference, Bangkok, Thailand, 2004.
49. Terris-Prestholt F, Kumaranayake L, Foster S, et al. The role of community acceptance over time for costs of HIV and STI prevention interventions: Analysis of the Masaka intervention trial, Uganda, 1996-1999. Sex Transm Dis. 2006; Feb. 7; PMID: 16505738.
50. Mandara NA, Takulia S, Kanyawana J, Mhalu F. Asymptomatic gonorrhoea in women attending family planning clinics in Dar es Salaam, Tanzania. Results of a pilot study. Trop Geogr Med 1980; 32:329-332.
51. Hira SK, Bhat GJ, Chikamata DM, et al. Syphilis intervention in pregnancy: Zambian demonstration project. Genitourin Med 1990; 66:159-164.
52. Schultz KF, Schulte J, Berman S. Maternal health and child survival: Opportunities to protect both women and children from the adverse consequences of reproductive tract infections. In: Germain A, ed. Reproductive Tract Infections. New York and London: Plenum Press, 1992:145-182.
53. Bastos dos Santos R, Folgosa E, Fransen L. Reproductive tract infections in Mozambique: A case study of integrated services. In: Germain A, ed. Reproductive Tract Infections. New York: Plenum Press, 1992:343-359.
54. Kigadye RM, Klokke A, Nicoll A, et al. Sentinel surveillance for HIV-1 among pregnant women in a developing country: 3 years' experience and comparison with a population serosurvey. AIDS 1993; 7:849-855.
55. Mayaud P, Grosskurth H, Changalucha J, et al. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics. Bull World Health Organ 1995; 73:621-630.
56. Jenniskens F, Obwaka E, Kirisuah S, et al. Syphilis control in pregnancy: Decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya. Int J Gynaecol Obstet 1995; 48(suppl):S121-128.
57. Mayaud P, Uledi E, Cornelissen J, et al. Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania. Sex Transm Infect 1998; 74(suppl 1):S139-146.
58. Fonck K, Claeys P, Bashir F, et al. Syphilis control during pregnancy: Effectiveness and sustainability of a decentralized program. Am J Public Health 2001; 91:705-707.
59. Bronzan R, Mwesgwa-Kayongo D, Narkuna D. Study of the feasibility, acceptability, performance, cost and cost-effectiveness of on-site testing for syphilis in rural antenatal clinics, Eastern Cape Province, Republic of South Africa. 2002.
60. Kumaranayake L, Muvira A. Cost Analysis of the Malawian ProTEST Initiative. World Health Organisation and Malawian National Tuberculosis Programme, 2004.
61. Levin C, Atherly D. Cost analysis of a syphilis rapid immunochromatographic strip (ICS) test in two central provinces of Mozambique. International Society of Sexually Transmitted Disease Research (ISSTDR), Amsterdam, Netherlands, 2004.
62. Nyamuryekung'e K, Laukamm-Josten U, Vuylsteke B, et al. STD services for women at truck stop in Tanzania: Evaluation of acceptable approaches. East Afr Med J 1997; 74:343-347.
63. Homan R, Damme van K. Estimating the cost and effectiveness of different STI management strategies for sex workers in Madagascar. Available at: http://www.popcouncil.org/pdfs/horizons/madswsum.pdf. 2002.
64. Muirhead D. The costs of a core group periodic presumptive treatment and education intervention in a mining community in South Africa: The Lesedi project. 2002.
65. Plessis du JL, Kahn JG, McConnel C. Sex work and HIV prevention in South Africa: How cost-efficient is it? 15th International AIDS Conference, Bangkok, Thailand, 2004.
66. Trebucq A, Louis JP, Tchupo JP, et al. Treatment regimens of STD patients in Cameroon: A need for intervention. Sex Transm Dis 1994; 21:124-126.
67. Van der Veen FH, Ndoye I, Guindo S, et al. Management of STDs and cost of treatment in primary health care centres in Pikine, Senegal. Int J STD AIDS 1994; 5:262-267.
68. La Ruche G, Lorougnon F, Digbeu N. Therapeutic algorithms for the management of sexually transmitted diseases at the peripheral level in Cote d'Ivoire: Assessment of efficacy and cost. Bull World Health Organ 1995; 73:305-313.
69. Crabbe F, Carsauw H, Buve A, et al. Why do men with urethritis in Cameroon prefer to seek care in the informal health sector? Genitourin Med 1996; 72:220-222.
70. Leiva A, Shaw M, Paine K, et al. Management of sexually transmitted diseases in urban pharmacies in The Gambia. Int J STD AIDS 2001; 12:444-452.
71. Connolly AM, Wilkinson D, Harrison A, et al. Inadequate treatment for sexually transmitted diseases in the South African private health sector. Int J STD AIDS 1999; 10:324-327.